Considering neuroinflammatory activity, NfL levels were an independent factor for the occurrence of at least one relapse during the first two years after MS diagnosis and for the occurrence of Gd+ lesions during the first 2 years from diagnosis at brain and spine MRI scans [121]. This evidence concerns the gene NEFL and myeloid sarcoma.